Caribou Biosciences Files 2024 10-K
Ticker: CRBU · Form: 10-K · Filed: Mar 10, 2025 · CIK: 1619856
| Field | Detail |
|---|---|
| Company | Caribou Biosciences, INC. (CRBU) |
| Form Type | 10-K |
| Filed Date | Mar 10, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, biotechnology
TL;DR
Caribou Bio's 2024 10-K is in. Check financials for FY24.
AI Summary
Caribou Biosciences, Inc. filed its 2024 10-K on March 10, 2025, reporting its fiscal year ended December 31, 2024. The company, focused on biological products, is incorporated in Delaware and headquartered in Berkeley, California. The filing details financial performance and business operations for the fiscal year 2024.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Caribou Biosciences' financial health and strategic direction for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a biotechnology company, Caribou Biosciences operates in a highly regulated and competitive industry with inherent risks related to research, development, and market adoption.
Key Players & Entities
- Caribou Biosciences, Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-03-10 (date) — Filing date
- Berkeley, CA (location) — Company headquarters
- DE (location) — State of incorporation
FAQ
What was Caribou Biosciences' revenue for the fiscal year ended December 31, 2024?
The provided text does not contain specific revenue figures for the fiscal year ended December 31, 2024.
What is the company's primary business focus?
Caribou Biosciences, Inc. is focused on Biological Products (No Diagnostic Substances).
When was the 10-K filing submitted?
The 10-K filing was submitted on March 10, 2025.
Where is Caribou Biosciences headquartered?
Caribou Biosciences, Inc. is headquartered at 2929 7th Street, Suite 105, Berkeley, CA 94710.
What is the SEC file number for this filing?
The SEC file number for this 10-K filing is 001-40631.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 10, 2025 regarding Caribou Biosciences, Inc. (CRBU).